A pilot randomized study of the neutrophil elastase inhibitor, Sivelestat, in patients undergoing cardiac surgery

Interactive Cardiovascular and Thoracic Surgery

Volumn 9, Issue 2, 2009, Pages 236-240

  Abe, Tomonobu ^a   Usui, Akihiko ^b   Oshima, Hideki ^b   Akita, Toshiaki ^c   Ueda, Yuichi ^b  

^a CHUKYO HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiopulmonary bypass; Coronary artery bypass grafts; Inflammatory response; Peri operative care; Pulmonary function

Indexed keywords

SIVELESTAT; SODIUM CHLORIDE;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LUNG ALVEOLUS OXYGEN TENSION; LUNG COMPLIANCE; LUNG FUNCTION; LUNG INJURY; MALE; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PILOT STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY SHUNT; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; TREATMENT OUTCOME; WOUND INFECTION;

AGED; ATRIAL FIBRILLATION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; FEASIBILITY STUDIES; FEMALE; GLYCINE; HUMANS; INFUSIONS, INTRAVENOUS; LENGTH OF STAY; LEUKOCYTE ELASTASE; LUNG COMPLIANCE; LUNG INJURY; MALE; MIDDLE AGED; PILOT PROJECTS; PULMONARY CIRCULATION; SERINE PROTEINASE INHIBITORS; SULFONAMIDES; SURGICAL WOUND INFECTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 68049084653     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.206193     Document Type: Article

References (15)

1. Taggart DP, el-Fiky M, Carter R, Bowman A, Wheatley DJ. Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg 1993;56:1123-1128.
2. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002;21:232-244. (Pubitemid 34135370)
3. Tonz M, Mihaljevic T, von Segesser LK, Fehr J, Schmid ER, Turina MI. Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible? Chest 1995;108:1551-1556.
4. Kawabata K, Suzuki M, Sugitani M, Imaki K, Toda M, Miyamoto T. ONO- 5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun 1991;177:814-820.
5. Yamazaki T, Ooshima H, Usui A, Watanabe T, Yasuura K. Protective effects of ONO-5046*Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury. Ann Thorac Surg 1999;68:2141-2146. (Pubitemid 30027838)
6. Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson TB Jr, Grover FL, Edwards FH. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003;75:1856-1864;discussion 1864-1865. (Pubitemid 36677229)
7. Tamakuma S, Ogawa M, Aikawa N, Kubota T, Hirasawa H, Ishizaka A, Taenaka N, Hamada C, Matsuoka S, Abiru T. Relationship between neutrophil elastase and acute lung injury in humans. Pulm Pharmacol Ther 2004;17:271-279. (Pubitemid 39345408)
8. Wakayama F, Fukuda I, Suzuki Y, Kondo N. Neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury after cardiopulmonary bypass in the rabbit endotoxemia model. Ann Thorac Surg 2007;83:153-160. (Pubitemid 44917894)
9. Matsuzaki K, Hiramatsu Y, Homma S, Sato S, Shigeta O, Sakakibara Y. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation. Ann Thorac Surg 2005;80:611-617. (Pubitemid 41019490)
10. Zeiher BG, Artigas A, Vincent JL, Dmitrienko A, Jackson K, Thompson BT, Bernard G. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 2004;32:1695-1702. (Pubitemid 39050520)
11. Suda K, Kitagawa Y, Ozawa S, Miyasho T, Okamoto M, Saikawa Y, Ueda M, Yamada S, Tasaka S, Funakoshi Y, Hashimoto S, Yokota H, Maruyama I, Ishizaka A, Kitajima M. Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus 2007;20:478-486. (Pubitemid 47617831)
12. Ono S, Tsujimoto H, Hiraki S, Takahata R, Kimura A, Kinoshita M, Ichikura T, Mochizuki H. Effects of neutrophil elastase inhibitor on progression of acute lung injury following esophagectomy. World J Surg 2007;31:1996-2001. (Pubitemid 47415716)
13. Yanatori M, Tomita S, Miura Y, Ueno Y. Feasibility of the fast-track recovery program after cardiac surgery in Japan. Gen Thorac Cardiovasc Surg 2007;55:445-449. (Pubitemid 350112797)
14. Nakano J, Okabayashi H, Hanyu M, Soga Y, Nomoto T, Arai Y, Matsuo T, Kai M, Kawatou M. Risk factors for wound infection after off-pump coronary artery bypass grafting: should bilateral internal thoracic arteries be harvested in patients with diabetes? J Thorac Cardiovasc Surg 2008;135:540-545.
15. Chaney MA, Durazo-Arvizu RA, Nikolov MP, Blakeman BP, Bakhos M. Methylprednisolone does not benefit patients undergoing coronary artery bypass grafting and early tracheal extubation. J Thorac Cardiovasc Surg 2001;121:561-569. (Pubitemid 32230225)